Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF
Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF Summary
Product Specifications
Human KIR2DL1/CD158a (His22-Arg242) Accession # P43626 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
1844-KR
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: KIR2DL1/CD158a
KIR2DL1 (2DL1, formerly NKAT1, designated CD158a) is a 348 amino acid (aa) type I transmembrane glycoprotein that belongs to the human killer cell Ig-like receptor (KIR) family (1, 2). KIRs are expressed on human CD56dim NK cells and T cell subsets, and regulate effector functions in the innate immune system (1-3). KIRs are named for the number of Ig-like domains (2D or 3D) in the extracellular domain (ECD), and whether they have long or short (L, S) cytoplasmic tails (1-3). Individuals will express varying subsets of inhibiting and activating KIRs with varying polymorphisms (1, 4). Like other inhibiting KIRs, KIR2DL1 has two ITIM domains within its long tail that block activating receptor clustering (2, 5). Within the ECD, KIR2DL1 shares high aa sequence identity (92%) with KIR2DL2. KIR2DL1 targets Lys80-containing HLA-C2 allotypes while KIR2DL2 rather recognizes Ans80 containing HLA-C1 (1, 6-8). Three KIRs proteins together (2DL1-3) recognize and inhibit NK cytotoxicity against cells expressing any HLA-C allotype, allowing self-recognition, but also conferring susceptibility to leukemia (1-3). In primary human NK cell clones, KIR2DL1 regulates the level of MHC I proteins expression required for NK cell inhibition (9).
- Purdy, A.K. and Campbell, K.S. (2009) Cancer Biol. Ther. 8:13.
- Lanier, L. L. (2005) Annu. Rev. Immunol. 23:225.
- Kulkarni, S. et al. (2008) Sem. Immunol. 20:343.
- Middleton, D. and F. Gonzelez (2009) Immunology 129:8.
- Abeyweera, T.P. et al. (2011) J. Cell Biol. 192:675.
- Moesta, A.K. et al. (2008) J. Immunol. 180:3969.
- Boyington, J.C. et al. (2000) Nature 405:537.
- Snyder, G.A. et al. (1999) Proc. Natl. Acad. Sci. USA 96:3864.
- Almeida, C.R. et al. (2011) PLoS ONE. 6:e24927.
Citations for Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
5
Citations: Showing 1 - 5
Filter your results:
Filter by:
-
HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells
Authors: P Fittje, A Hœlzemer, WF Garcia-Bel, S Vollmers, A Niehrs, K Hagemann, G Martrus, C Körner, F Kirchhoff, D Sauter, M Altfeld
Oncogene, 2022-06-24;18(6):e1010572.
Species: Human
Sample Types: Recombinant Proteins
Applications: Bioassay -
Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C
Authors: MJW Sim, S Rajagopala, DM Altmann, RJ Boyton, PD Sun, EO Long
Proc. Natl. Acad. Sci. U.S.A., 2019-05-28;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection
Authors: N Wauquier, C Petitdeman, N Tarantino, C Maucourant, M Coomber, V Lungay, J Bangura, P Debré, V Vieillard
EBioMedicine, 2019-01-30;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Peptide-specific engagement of the activating NK cell receptor KIR2DS1
Authors: A Chapel, WF Garcia-Bel, A Hölzemer, M Ziegler, S Lunemann, G Martrus, M Altfeld
Sci Rep, 2017-05-25;7(1):2414.
Applications: Bioassay -
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors.
Authors: Cifaldi L, Romania P, Falco M, Lorenzi S, Meazza R, Petrini S, Andreani M, Pende D, Locatelli F, Fruci D
Cancer Res, 2015-01-15;75(5):824-34.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human KIR2DL1/CD158a Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image